NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies ...
--Annovis Bio Inc., a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer’ s disease and Parkinson’ s disease, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results